Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Seminars in Oncology|December 22, 1999
Daily oral estramustine and intermittent intravenous docetaxel (Taxotere) as chemotherapeutic treatment for metastatic, hormone-refractory prostate cancerW Kreis, D BudmanThe Journal of Experimental Medicine|August 1, 1971
Specificity of fixation loci for homocytotropic antibodiesJ R Battisto, D Budman, R FreedmanOncology Reports|May 20, 2011
Involvement of prostate specific antigen in the stimulation of LNCaP cell growthL Wang, X Liu, W Kreis, et al.Cancer Clinical Trials|January 1, 1981
Tamoxifen in unresectable hypernephroma. A phase II trial and review of the literatureL Weiselberg, D Budman, V Vinciguerra, et al.Archives of Internal Medicine|August 1, 1984
Kappa-chain nephropathy associated with plasma cell leukemiaA Rahman, R T Mossey, M Susin, et al.Cancer|February 1, 1981
Electron microscope cytochemical analysis of chronic myelocytic leukemia: a case reportL Weiselberg, S Teichberg, V Vinciguerra, et al.Cancer Genetics and Cytogenetics|March 1, 1981
Association of monosomy 7 with myelodysplasia following chemotherapy for Hodgkin's disease: serial observationsJ Kross, P Schulman, N Kardon, et al.The American Journal of Gastroenterology|January 1, 1985
Evaluation of colonic neoplasia by flow cytometry of endoscopic biopsiesM McKinley, D Budman, W Caccese, et al.Cancer Chemotherapy and Pharmacology|January 1, 1985
Phase-II trial of 4-demethoxydaunorubicin (DMDR) for advanced hypernephromaH I Scher, A Yagoda, T Ahmed, et al.Leukemia|December 1, 1994
Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: a report of CALGB study 8515H M Golomb, R Dodge, R Mick, et al.Pageof 3